Retatrutide (LY3437943) is an investigational peptide being studied as a once-weekly triple agonist of the glucagon, GIP, and GLP-1 receptors. Clinical research is evaluating its effects on metabolic parameters, body weight, and related outcomes. It remains an investigational compound.

Peptide: Retatrutide
Development Code: LY3437943
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4,731 g/mol
CAS Number: 2381089-83-2
Available Strength: 16 mg
Category: Investigational Peptide

Note: The molecular formula above corresponds to the retatrutide sodium-salt reference record. Exact molecular weight/formula can vary with the salt or formulation; the product COA should be used for the exact material supplied.

For Research Use Only. Not for Human Consumption.